Harmon DTC is a recurring revenue roll-up platform for high-margin DTC health & wellness brands โ which has launched a GLP-1 Metabolic Health Offering built on 50 years of brand trust and 12 million customer data points.
๐ณ All major credit cards accepted
Every Harmon DTC investor earns tangible benefits โ the more and earlier you invest, the more you unlock.
Earn up to 20% bonus shares for investing early and at higher tiers.
Complimentary GLP-1 subscription months โ up to a full 6-month program.
Free Harmon Health Club membership with exclusive pricing and member-only benefits.
Be first to try new product launches โ and access future investment rounds.
Every tier unlocks exclusive benefits โ including free GLP-1 subscriptions, Harmon Health Club memberships, and bonus shares.
Invest early and earn additional bonus shares.
The more you invest, the more you unlock.
๐ณ All major credit cards accepted
โ๏ธ All perks will be confirmed and sent via email. For any and all other questions on perks, email Hello@harmon.health.
Disclaimer: Each free month provided as an investor perk may be applied, at the investor's choice, toward a compounded GLP-1 (Semaglutide and Tirzepatide) subscription or an alternative therapy โ NAD+, Sermorelin, Glutathione, B12, or MICC โ as available on our Harmon.Health website. The value of the free months is based on an average price of $200.00 per month for GLP-1 compounded injectables; alternative therapies may vary in price.
Harmon DTC is positioned at the intersection of three converging massive market forces.
1 Source: Global Wellness Institute, U.S. Wellness Economy Report (March 2025). See globalwellnessinstitute.org. Market data is for informational purposes only and not a guarantee of returns.
Massive growth, chronic use, and recurring revenue from a category experiencing explosive adoption โ with GLP-1 and peptide expansion further accelerating tailwinds.
A large, fragmented brand landscape with distressed acquisition targets emerging post-2021 CAC spike. Harmon's infrastructure gives it an edge in integrating and scaling these brands.
Recurring revenue models drive predictably higher valuation multiples. Harmon's entire platform is being designed for subscription-first, continuity-based customer relationships.
Demand for GLP-1 and anti-obesity treatment is set to accelerate over the next decade.
Branded GLP-1 prescriptions are growing roughly 16ร faster than the overall U.S. prescription market.
Disclaimer: All data and statistics in this section are sourced from Morgan Stanley Research (as of July 2026). Market figures are estimates and are not a guarantee of future results.
Search volume and consumer interest for GLP-1 and compounded GLP-1 products have grown dramatically โ and Harmon is positioned to capture this wave.
Consumer demand for GLP-1 supplements and compounded GLP-1 products has grown +844% in two years. Harmon DTC is entering this category with a trusted brand, owned customer data, and a lower CAC than any competitor โ at exactly the right moment.
Harmon enters the DTC health and wellness market with structural advantages that most companies spend years and millions of dollars trying to build.
Multi-generational brand equity with deep roots in the NY/NJ metro area. Customers don't just buy โ they trust.
Harmon can sell to an existing base rather than spending heavily on new customer acquisition โ a massive cost advantage.
50 years of earned consumer trust across health, beauty, and wellness. A heritage brand launching into a high-growth category.*
Harmon DTC owns millions of customer data points โ enabling precision targeting and dramatically lower CAC vs. competitors.
*Parent Company Harmon is a 50-year-old brand
Harmon DTC is executing a focused three-part strategy to build a high-margin, recurring-revenue health and wellness platform.
Telehealth-enabled prescription GLP-1 and peptide programs on a subscription model. High retention category with strong cross-sell into supplements and beauty.
Centralized marketing, data, fulfillment, and regulatory infrastructure that reduces costs for every brand on the platform and improves lifetime value.
Acquire undervalued brands, integrate them into the shared stack, improve LTV/CAC, and expand distribution โ creating compounding value with each acquisition.
From first contact to long-term subscription โ Harmon owns the full patient lifecycle with lower CAC than any competitor.
Unlike most startups, Harmon DTC is backed by hard assets, proprietary data, and decades-old brand IP โ from day one.
All trademarks for the Harmon brand โ one of the most recognized health & wellness names in the Northeast.
Full trademark portfolio for Face Values Private Label brand โ a proven beauty and personal care line.
Millions of verified, high-intent health & wellness customer records โ among the most valuable assets in DTC.
All URLs across Harmon and Face Values โ plus 4+ years of granular sales, product, and channel data by brand and SKU.
Backed by executives with 20โ40+ years of experience across retail, beauty, brand management, and CPG.
Executive Chair at L&R Distributors. Former President and CEO with over 30 years of beauty product ownership and leadership.
Partner and Investor at Springview Investments. Former COO and Board Member at Marquee Brands. Founder of Consortium Brands.
Owner of National Wholesale Liquidators for 15+ years. Deep retail operations expertise in the NY/NJ metro market.
Former CMO at Burlington Discount and Bed Bath. Former Partner at McKinsey. Executive roles at Smuckers, Big Heart Pet Brands, Kraft, and Campbell Soup.
Former Chairman of the Board at Nautilus. Extensive background in brand development and corporate governance across major consumer categories.
Browse our complete investor presentation below.
Invest in a 50-year brand entering its highest-growth chapter โ at $0.50 per share.
Invest Now๐ณ All major credit cards accepted